Ginkgo Biloba Extract for Diabetic Eye Disease
Part of Eyes & vision clinical trials.
This trial tests whether an extract from the ginkgo tree can help prevent or slow vision loss in people with diabetes who have early signs of diabetic retinopathy. It is for patients who have not yet received eye treatments like laser or injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had diabetes for at least 5 years.
- You either have no diabetic retinopathy or only mild to moderate early-stage retinopathy without swelling in the center of the retina.
- You have not taken ginkgo biloba extract in the past 12 months.
- You have not had any eye treatments such as laser, injections, or surgery for diabetic eye disease.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new eye drop, NPDR-01, can help slow or improve early diabetic retinopathy (damage to the retina caused by diabetes). It is for people with type 1 or type 2 diabetes who have non-proliferative diabetic retinopathy and have not had certain eye treatments.
This study tests whether a supplement called N-acetyl cysteine can help slow or improve mild to moderate diabetic eye disease (diabetic retinopathy). The goal is to see if it's safe and effective for people with type 2 diabetes.
This trial tests if a targeted laser treatment guided by a special eye scan can slow the progression of blocked blood vessels in the retina for people with diabetes-related eye disease. It may help preserve vision by treating damaged areas before they worsen.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
This early-phase study tests a treatment aimed at preventing or slowing early diabetic eye disease in people with mild, early changes. You may be considered if your diabetes is moderately controlled and your eye tests show early warning signs.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
Hear when a new Non-proliferative Diabetic Retinopathy (NPDR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.